Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.

Annals of medicine - 1 Aug 1994

Hörkkö S, Huttunen K, Läärä E, Kervinen K, Kesäniemi Y A

Abstract excerpt

Plasma lipids, chemical composition of various lipoprotein fractions, apolipoprotein B concentrations and apolipoprotein E phenotypes were studied in 12 uraemic patients on conservative treatment (CT), in 16 patients on haemodialysis (HD) and in 18 patients on continuous ambulatory peritoneal dialysis treatment (CAPD). Plasma total cholesterol and triglyceride concentrations were increased in the CAPD patients in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoproteins E
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Lipids

Share to Lipoproteins

Share to Logistic Models

Share to Phenotype

Source

Identifiers

PMID: 7946245
DOI: 10.3109/07853899409147902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.PMID 7946245Read ↗

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.Semantic proximity Read ↗

Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.Semantic proximity Read ↗

Elevated TG/HDL-C and Non-HDL-C/HDL-C Ratios Predict Mortality in Peritoneal Dialysis PatientsSemantic proximity Read ↗

Paraoxonase activity in healthy, diabetic, and hemodialysis patients.Semantic proximity Read ↗

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.Semantic proximity Read ↗

Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.Semantic proximity Read ↗

A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients.Semantic proximity Read ↗

Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.Semantic proximity Read ↗

Impaired triglyceride tolerance in hemodialysis patients with different apolipoprotein E (apo E) isoforms.Semantic proximity Read ↗

Effect of apolipoprotein e polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patientsSemantic proximity Read ↗

Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.Semantic proximity Read ↗

Serum paraoxonase activities in hemodialyzed uremic patients: cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.